Countries Europe
Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French public hospitals, in collaboration with Fujifilm L...
September 12, 2025 | News
The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the Innovation Award 2025 of the St...
September 11, 2025 | News
Manufacturing excellence positions Seattle site as premier destination for mammalian and microbial biologic production in thriving Pacific Northwest life...
September 11, 2025 | News
Evonik, a global specialty chemicals company, and Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, ...
September 10, 2025 | News
Servier, an independent international pharmaceutical group governed by a foundation, announced that it has entered into a definitive agreement with Kaerus ...
September 09, 2025 | News
In 2025, sustainable innovation has become a core focus in biotechnology and biopharmaceutical industries worldwide. Private companies are at the forefront...
September 08, 2025 | Analysis
-Biocytogen Pharmaceuticals , a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative te...
September 05, 2025 | News
hermo Fisher Scientific announced the launch of Invitrogen™ UltraComp eBeads™ Spectral Unmixing Beads, a breakthrough solution designed t...
September 05, 2025 | News
Integration with NVIDIA Omniverse libraries via OpenXR runtime supports enhanced spatial awareness for industrial designs and simulations Partnership wi...
September 04, 2025 | News
Speech Processing Solutions (SPS), the global leader behind Philips SpeechLive, announced a strategic partnership with Corti, the specialized AI infr...
September 04, 2025 | News
Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening Lunit , a leading provider o...
September 03, 2025 | News
AstraZeneca announced positive full results from the BaxHTN Phase III trial, showing that baxdrostat, a first-in-class aldosterone synthase inhibitor, achi...
September 02, 2025 | News
Daiichi Sankyo Europe announced the initiation of the development of new oral triple combination tablets in Europe containing bempedoic acid, ezetimibe, an...
September 02, 2025 | News
Eligible patients can receive TTFields therapy through the Spanish National Health System Novocure announced that Spain’s Ministry of Heal...
August 26, 2025 | News
Most Read
Bio Jobs
News
Editor Picks